Stockreport

Personalis outlines 170% clinical test volume growth target for 2026 as reimbursement and MRD strategy accelerate [Seeking Alpha]

Personalis, Inc.  (PSNL) 
Last personalis, inc. earnings: 3/25 04:01 pm Check Earnings Report
PDF Chris Hall, President and CEO, highlighted, "2025 was the year we validated our winning MRD strategy. 2026 is the year we expect to scale. Physicians increasingly trust [Read more]